Kintegral Advisory
CL icon

Kintegral Advisory’s Colgate-Palmolive CL Stock Holding History

Kintegral Advisory’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.36M Buy
15,975
+90
+0.6% +$8.15K 0.11% 154
2026
Q2 		$1.46M Hold
15,885
– – 0.12% 150
2026
Q1 		$1.35M Sell
15,885
-704
-4% -$62.7K 0.13% 152
2025
Q4 		$1.31M Sell
16,589
-454
-3% -$35.6K 0.11% 156
2025
Q3 		$1.36M Sell
17,043
-76
-0.4% -$6.48K 0.12% 156
2025
Q2 		$1.56M Sell
17,119
-26
-0.2% -$2.37K 0.14% 146
2025
Q1 		$1.61M Sell
17,145
-58
-0.3% -$5.19K 0.16% 137
2024
Q4 		$1.56M Sell
17,203
-802
-4% -$76.5K 0.15% 144
2024
Q3 		$1.87M Sell
18,005
-236
-1% -$24.1K 0.17% 133
2024
Q2 		$1.77M Sell
18,241
-53,122
-74% -$4.9M 0.17% 131
2024
Q1 		$6.43M Sell
71,363
-222
-0.3% -$18.8K 0.64% 37
2023
Q4 		$5.71M Sell
71,585
-456
-0.6% -$34.3K 0.63% 40
2023
Q3 		$5.12M Sell
72,041
-43
-0.1% -$3.22K 0.63% 39
2023
Q2 		$5.55M Hold
72,084
– – 0.66% 39
2023
Q1 		$5.42M Sell
72,084
-3,873
-5% -$288K 0.7% 39
2022
Q4 		$5.98M Buy
75,957
+52,166
+219% +$3.91M 0.79% 32
2022
Q3 		$1.67M Hold
23,791
– – 0.23% 107
2022
Q2 		$1.91M Buy
23,791
+504
+2% +$39.4K 0.25% 98
2022
Q1 		$1.77M Buy
23,287
+521
+2% +$41.3K 0.19% 113
2021
Q4 		$1.94M Hold
22,766
– – 0.2% 114
2021
Q3 		$1.72M Hold
22,766
– – 0.2% 117
2021
Q2 		$1.85M Hold
22,766
– – 0.22% 111
2021
Q1 		$1.8M Hold
22,766
– – 0.23% 107
2020
Q4 		$1.95M Hold
22,766
– – 0.26% 96
2020
Q3 		$1.76M Sell
22,766
-733
-3% -$55.9K 0.27% 92
2020
Q2 		$1.72M Hold
23,499
– – 0.28% 90
2020
Q1 		$1.56M Buy
23,499
+2,629
+13% +$185K 0.3% 86
2019
Q4 		$1.44M Hold
20,870
– – 0.26% 99
2019
Q3 		$1.53M Hold
20,870
– – 0.31% 93
2019
Q2 		$1.5M Hold
20,870
– – 0.3% 94
2019
Q1 		$1.43M Buy
20,870
+10,930
+110% +$706K 0.3% 95
2018
Q4 		$592K Buy
+9,940
New +$622K 0.18% 115

Other funds holding CL

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Sarasin & Partners
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
PineStone Asset Management
PineStone Asset Management Montreal, Quebec, Canada $15.4B AUM 14.92% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Avity Investment Management
Avity Investment Management Greenwich, Connecticut $1.6B AUM 32.15% 1-Year Est. Return

Kintegral Advisory's CL Position: Q3 2026 in Review

Kintegral Advisory increased its Colgate-Palmolive (CL) stake by 0.57% in Q3 2026, buying an estimated $8.15K and bringing the position to 15,975 shares worth $1.36M. The position accounts for 0.11% of the portfolio, ranked #154.

Kintegral Advisory first reported a position in CL in Q4 2018 and has held it in 32 quarters since. The position peaked at $6.43M in Q1 2024. 384 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Kintegral Advisory held 15,975 shares of Colgate-Palmolive worth $1.36M as of Q3 2026.
  • Kintegral Advisory bought 90 Colgate-Palmolive shares in Q3 2026, an estimated $8.15K.
  • Colgate-Palmolive made up 0.11% of Kintegral Advisory's portfolio in Q3 2026, its #154 holding.
  • Kintegral Advisory first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 32 quarters since.
  • Kintegral Advisory's Colgate-Palmolive position peaked at $6.43M in Q1 2024.
  • 384 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Kintegral Advisory's 13F filing for Q3 2026, filed 16 Oct 2026.